stem cells
StemCells Inc. (STEM) to Present Study Results at the Society for Neuroscience Annual Meeting in Washington, D.C.
Read the full article: http://Blog.QualityStocks.net/?p=13851
StemCells Inc. (Nasdaq: STEM) is a clinical-stage biotechnology company focused on the development and commercialization of cell-based therapeutics to treat diseases of the central nervous system and liver. Though controversial to many people, cell-based discoveries are important in medical and scientific advances.
- Login or register to post comments
- Email this page
Related Articles
- StemCells Inc. (STEM) to Present Study Results at the Society for Neuroscience Annual Meeting in Washington, D.C.
- Is it Time Yet for Solar? A Look at the Leaders (SPWRA, FSLR)
- Micromet Inc. (MITI) Presents Positive Clinical Trial Results to Hematology Society
- Online Tutorial: Boon For Autistic Children
- Online Tutorial: Boon For Autistic Children